Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both Wegovy and compounded semaglutide use the same GLP-1 receptor agonist molecule to reduce appetite and slow gastric emptying. The key difference lies not in strength but in sourcing, regulatory pathways, and your out-of-pocket cost. Understanding these distinctions helps you make an informed choice about your weight loss medication.

What Makes Wegovy and Compounded Semaglutide Different

Wegovy is a brand-name injectable semaglutide manufactured by Novo Nordisk under FDA approval for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Compounded semaglutide is the same active pharmaceutical ingredient (API) formulated by licensed 503A compounding pharmacies to meet individual patient needs. Both formulations deliver identical semaglutide molecule doses when prescribed at equivalent levels.

The practical difference centers on production and distribution. Wegovy undergoes centralized manufacturing with standardized supply chains, while compounded versions are prepared in state-regulated compounding facilities. Neither approach is inherently stronger—both rely on the same mechanism of action when dosed appropriately. Your body's response depends on your individual GLP-1 receptor genetics and metabolic pathways, not the source of the medication.

Cost Comparison: Why Compounded Semaglutide Often Costs Less

Wegovy typically costs $900–$1,300 per month through traditional pharmacy channels, even with insurance, due to high manufacturing and marketing expenses. PlexusDx compounded semaglutide injection starts at $149/month regardless of dose level, with your dose able to increase without price increases. This pricing model removes the financial barrier many patients face when accessing GLP-1 therapy.

Insurance coverage for Wegovy remains inconsistent and often requires prior authorization or proof of weight-related comorbidities. PlexusDx serves all 50 states without requiring insurance, making compounded semaglutide accessible to uninsured and underinsured patients. Both options are HSA and FSA eligible, but compounded pricing transparency means you know your monthly cost upfront.

Effectiveness: Both Contain Identical Active Ingredient

Clinical trials demonstrate semaglutide produces weight loss of 5–18% of body weight depending on dose and individual response, a finding that applies equally to brand-name and compounded formulations. The active molecule is biochemically identical regardless of manufacturing source. Your results depend on consistent dosing, lifestyle factors, and genetic predisposition to GLP-1 receptor sensitivity rather than whether your semaglutide comes from Novo Nordisk or a compounding pharmacy.

Individual variation in response is significant: some patients achieve 10% loss within three months, while others reach 15% over six months. PlexusDx offers the Precision Peptide Genetic Test to identify your GLP1R rs6923761 variant and other peptide-pathway markers, helping predict your likely response and optimal compound selection. This personalization approach recognizes that medication strength matters less than medication-person match.

Access and Availability: Compounded Semaglutide Reaches All 50 States

Wegovy supply has faced periodic shortages since its 2021 FDA approval, limiting availability for new and existing patients. Compounded semaglutide produced by licensed 503A compounding pharmacies maintains consistent supply because multiple facilities can prepare formulations simultaneously. PlexusDx patients can begin treatment within days of consultation without waiting lists or rationing concerns.

Telehealth availability also favors compounded options: PlexusDx connects patients with prescribers across all states without geographic restrictions. Wegovy requires in-person or telehealth visits through specific provider networks, which may limit scheduling flexibility. For patients in rural areas or with complex schedules, compounded semaglutide through telemedicine often proves more practical.

Personalization: Understanding Your Genetic Response to GLP-1

Not all patients respond identically to semaglutide, whether brand-name or compounded. Genetic variation in your GLP-1 receptor gene (GLP1R rs6923761) influences how effectively the medication binds to your cells and triggers appetite suppression. PlexusDx Precision Peptide Genetic Test identifies your specific variants across 14 pathways and 49 peptides, revealing whether you're a strong responder, moderate responder, or require alternative compounds like tirzepatide.

This genetic insight eliminates guesswork: instead of trial-and-error dosing, PlexusDx matches your genetic profile to the optimal GLP-1 or dual-peptide compound from the start. Your pharmacist and prescriber receive a detailed report showing which peptide pathways drive your weight regulation, whether compounded semaglutide alone will suffice or if GLP-Squared (semaglutide plus tirzepatide) better targets your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as strong as Wegovy?

Yes. Both contain identical semaglutide molecules and produce equivalent weight loss when dosed at the same levels. Strength depends on dose, not source. Your personal response depends on your genetics and lifestyle, not whether your medication is manufactured by Novo Nordisk or a licensed 503A compounding pharmacy.

Why does compounded semaglutide cost so much less than Wegovy?

Wegovy's cost includes brand development, FDA approval, and centralized manufacturing overhead. Compounded semaglutide from licensed 503A pharmacies eliminates these expenses by using established API sources and decentralized production. PlexusDx passes these savings directly to patients: semaglutide injection starts at $149/month with no your dose may need to go up - your price won't goes up.

Will I get the same results from compounded semaglutide as Wegovy?

Results depend on your individual metabolic genetics, not medication source. Most patients on semaglutide achieve 5–18% body weight loss over 6–12 months. PlexusDx Precision Peptide Genetic Test predicts your likely response category and identifies whether you'll benefit more from semaglutide alone or a dual-compound approach tailored to your peptide pathways.

Is compounded semaglutide safe if it's not FDA-approved?

Compounded semaglutide uses FDA-approved semaglutide API (the active ingredient) prepared by licensed 503A compounding pharmacies regulated by state boards of pharmacy. While the formulation itself isn't FDA-approved as a brand product, the ingredient and preparation standards meet rigorous safety requirements. Always disclose your compounded medication to your healthcare team.

How does PlexusDx genetic testing help me choose between semaglutide and Wegovy?

The Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants to predict semaglutide responsiveness and identify whether tirzepatide or dual-compound therapy better matches your biology. This personalization ensures you start on the right medication—compounded or otherwise—based on your unique peptide pathways, not trial and error.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves